Prodia Diagnostic Line Tbk vs Sarana Meditama Metropolitan Tbk. — how do they compare? Prodia Diagnostic Line Tbk trades at Rp270 (market cap 474.07B, 21.23M 24h volume), while Sarana Meditama Metropolitan Tbk. trades at Rp296 (market cap 5.15T, 335.5K 24h volume). The key difference: Sarana Meditama Metropolitan Tbk. is far larger — about 10.9× Prodia Diagnostic Line Tbk's market cap, and Prodia Diagnostic Line Tbk is more actively traded (21.23M versus 335.5K). Which is the better fit depends on your goals.
| PRDL | SAME | |
|---|---|---|
Market Cap | 474.07B | 5.15T |
Volume | 21.23M | 335.5K |
Lot | 212.3K | 3.36K |
Turnover | 5.77B | 99.9M |
Average Price | 271.63 | 297.77 |
Value | 5.77B | 99.9M |
Indicative Equilibrium Price | 270 | 296 |
Indicative Equilibrium Volume | 2.21K | 275 |
Trailing returns across standard periods
Latest headlines on both assets
PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.
Read more on PRDL →PT Sarana Meditama Metropolitan (the Company) was established based on Notarial Deed No. 27 of Budiarti Karnadi, S.H., dated November 13, 1984
Read more on SAME →